Investing.com -- Microsoft Corp. has committed more than $60 billion to neocloud data center companies as the tech giant races to secure enough computing capacity for its artificial intelligence needs ...

Lattice Semiconductor (NASDAQ:LSCC) leads the pack with Jefferies maintaining a Buy rating while boosting its price target to $85 from $65. Analysts see LSCC as well-positioned for a strong return to ...

Investing.com -- American Airlines (NASDAQ:AAL) stock fell 2.75% Tuesday, while Delta Air Lines (NYSE:DAL) dropped 2.9% and United Airlines (NASDAQ:UAL) declined 2.5% amid broad market weakness and ...

The budget Mac, currently code-named J700, is designed to appeal to students, businesses, and casual users who primarily browse the web, work on documents, or perform light media editing, according to ...

Deutsche Bank also pointed to the inelastic nature of Chinese gold demand. “China investment demand through ETFs was seen to ...

Moody’s Ratings has upgraded JPMorgan Chase Bank’s long-term deposit rating to Aa1 from Aa2, while maintaining a stable ...

Investing.com -- Moody’s Ratings has downgraded Wayfair LLC’s senior secured notes ratings to B2 from B1 while affirming the company’s B3 corporate family rating (CFR), the ratings agency announced ...

The positive outlook reflects S&P’s expectation that AvalonBay will achieve high occupancy and steady rental rate growth over the next two years, supported by continued demand for quality, ...

Wayfair’s operating results in the second and third quarters of 2025 exceeded S&P’s expectations, with revenue increasing nearly 5% year-over-year and adjusted EBITDA rising 35%. The company’s EBITDA ...

S&P expects Nabors to use the $250 million seller note proceeds to further reduce debt, focusing on its upcoming 2028 maturity. The rating agency forecasts Nabors’ adjusted debt will decrease to ...

Investing.com -- S&P Global Ratings has revised its outlook for Equity Residential (NYSE:EQR) to positive from stable while affirming the company’s ratings, citing solid operating performance and ...

Investing.com -- CytomX Therapeutics Inc (NASDAQ:CTMX) stock gained 4% Tuesday following the announcement that initial translational data from its Phase 1 study of CX-801 in advanced melanoma patients ...